rs1800795

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000325042.2(IL6-AS1):​n.54-321G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.67 in 554,376 control chromosomes in the GnomAD database, including 131,638 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as other,risk factor (no stars).

Frequency

Genomes: 𝑓 0.72 ( 41246 hom., cov: 29)
Exomes 𝑓: 0.65 ( 90392 hom. )

Consequence

IL6-AS1
ENST00000325042.2 intron

Scores

2

Clinical Significance

other; risk factor no assertion criteria provided O:7

Conservation

PhyloP100: 3.25

Publications

2714 publications found
Variant links:
Genes affected
IL6-AS1 (HGNC:40301): (IL6 antisense RNA 1)
IL6 (HGNC:6018): (interleukin 6) This gene encodes a cytokine that functions in inflammation and the maturation of B cells. In addition, the encoded protein has been shown to be an endogenous pyrogen capable of inducing fever in people with autoimmune diseases or infections. The protein is primarily produced at sites of acute and chronic inflammation, where it is secreted into the serum and induces a transcriptional inflammatory response through interleukin 6 receptor, alpha. The functioning of this gene is implicated in a wide variety of inflammation-associated disease states, including suspectibility to diabetes mellitus and systemic juvenile rheumatoid arthritis. Elevated levels of the encoded protein have been found in virus infections, including COVID-19 (disease caused by SARS-CoV-2). [provided by RefSeq, Aug 2020]
STEAP1B (HGNC:41907): (STEAP family member 1B) Predicted to be integral component of membrane. Predicted to be active in endosome and plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.975 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IL6NM_000600.5 linkc.-237C>G upstream_gene_variant ENST00000258743.10 NP_000591.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IL6ENST00000258743.10 linkc.-237C>G upstream_gene_variant 1 NM_000600.5 ENSP00000258743.5

Frequencies

GnomAD3 genomes
AF:
0.716
AC:
108695
AN:
151800
Hom.:
41177
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.927
Gnomad AMI
AF:
0.615
Gnomad AMR
AF:
0.789
Gnomad ASJ
AF:
0.737
Gnomad EAS
AF:
0.998
Gnomad SAS
AF:
0.841
Gnomad FIN
AF:
0.476
Gnomad MID
AF:
0.820
Gnomad NFE
AF:
0.577
Gnomad OTH
AF:
0.738
GnomAD4 exome
AF:
0.652
AC:
262377
AN:
402458
Hom.:
90392
AF XY:
0.661
AC XY:
139725
AN XY:
211226
show subpopulations
African (AFR)
AF:
0.935
AC:
10202
AN:
10910
American (AMR)
AF:
0.816
AC:
11884
AN:
14558
Ashkenazi Jewish (ASJ)
AF:
0.739
AC:
9148
AN:
12384
East Asian (EAS)
AF:
0.999
AC:
27354
AN:
27374
South Asian (SAS)
AF:
0.821
AC:
32241
AN:
39258
European-Finnish (FIN)
AF:
0.459
AC:
12423
AN:
27070
Middle Eastern (MID)
AF:
0.798
AC:
1426
AN:
1788
European-Non Finnish (NFE)
AF:
0.577
AC:
141674
AN:
245580
Other (OTH)
AF:
0.681
AC:
16025
AN:
23536
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
3747
7494
11241
14988
18735
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
762
1524
2286
3048
3810
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.716
AC:
108822
AN:
151918
Hom.:
41246
Cov.:
29
AF XY:
0.718
AC XY:
53336
AN XY:
74234
show subpopulations
African (AFR)
AF:
0.927
AC:
38449
AN:
41456
American (AMR)
AF:
0.789
AC:
12057
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.737
AC:
2559
AN:
3472
East Asian (EAS)
AF:
0.998
AC:
5133
AN:
5142
South Asian (SAS)
AF:
0.841
AC:
4038
AN:
4804
European-Finnish (FIN)
AF:
0.476
AC:
5009
AN:
10530
Middle Eastern (MID)
AF:
0.827
AC:
243
AN:
294
European-Non Finnish (NFE)
AF:
0.577
AC:
39216
AN:
67930
Other (OTH)
AF:
0.740
AC:
1558
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1318
2636
3955
5273
6591
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
812
1624
2436
3248
4060
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.639
Hom.:
4111
Bravo
AF:
0.750
Asia WGS
AF:
0.914
AC:
3175
AN:
3478

ClinVar

Significance: other; risk factor
Submissions summary: Other:7
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Crohn disease-associated growth failure, susceptibility to Other:1
Sep 01, 2007
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Diabetes mellitus, type 1, susceptibility to Other:1
Sep 01, 2007
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Diabetes mellitus type 2, susceptibility to Other:1
Sep 01, 2007
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

INTRACRANIAL HEMORRHAGE IN BRAIN CEREBROVASCULAR MALFORMATIONS, SUSCEPTIBILITY TO Other:1
Sep 01, 2007
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Kaposi sarcoma Other:1
Sep 01, 2007
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Cholangiocarcinoma Other:1
Dec 10, 2022
Department of Surgery, Campus Charité Mitte Campus Virchow-klinikum, Charite-Universitaetsmedizin Berlin
Significance:other
Review Status:no assertion criteria provided
Collection Method:research

No association with disease-free or overall survival after resection of intrahepatic Cholangiocarcinoma No association with disease-free or overall survival

RHEUMATOID ARTHRITIS, SYSTEMIC JUVENILE, SUSCEPTIBILITY TO Other:1
Sep 01, 2007
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
16
DANN
Benign
0.70
PhyloP100
3.3
PromoterAI
0.046
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1800795; hg19: chr7-22766645; API